Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...
The Trump administration is delaying a voluntary model that aimed to expand access to GLP-1s in Part D after pushback from ...
CMS pauses weight-loss BALANCE model for Medicare Part D after insufficient plan sponsor participation, while Medicaid pilot continues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results